Doctors advised the model to undergo a mastectomy with radiation, chemotherapy, hormone therapy and a breast reconstruction.
Vous n'êtes pas connecté
Cancer remains one of the most challenging diseases to treat due to its complexity and tendency to metastasize (spread into or invade, nearby tissues or distant places in the body to form new tumors). Traditional therapies, such as chemotherapy and radiation, often face limitations like non-specific targeting and severe side effects. In response, researchers are turning to innovative approaches that combine multiple therapeutic modalities to address these issues. This study explores a cutting-edge solution involving CNHs to create a multimodal cancer phototheranostic platform integrating photothermal therapy (PTT), immunotherapy, and chemotherapy.
Doctors advised the model to undergo a mastectomy with radiation, chemotherapy, hormone therapy and a breast reconstruction.
Following surgery, doctors advised the model to undergo a mastectomy with radiation, chemotherapy and a breast reconstruction.
Breast cancer is the leading cancer among Indian women, especially in urban regions due to lifestyle shifts. Early detection challenges contribute to...
Shorter-course radiation therapy is a more efficient and equally effective option for breast cancer patients compared to traditional longer...
A recent study by Ludwig Cancer Research has uncovered a crucial metabolic switch in the immune system’s T cells that plays a vital role in creating...
Delivering higher doses of radiation therapy in fewer sessions after medlinkbreast cancer surgery/medlink can significantly reduce side effects and
Delivering higher doses of radiation therapy in fewer sessions after medlinkbreast cancer surgery/medlink can significantly reduce side effects and
Precision in radiation treatment plans is central to cancer patient care, carried out by medical dosimetrists who collaborate closely with specialists...
TC BioPharm (Holdings) PLC (TC BioPharm), a clinical stage biotechnology company developing platform allogeneic gamma─delta T cell therapies for...
A new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor therapies work together to recruit new...